Science
Mechanism of Action
The precise mechanism by which SH-OLIGOPEPTIDE-89 SP interacts with skin cellular processes to exert any potential benefits remains uncharacterized in available scientific literature.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Data is currently insufficient to determine if SH-OLIGOPEPTIDE-89 SP is commonly formulated at concentrations below a theoretically efficacious threshold.
The Formula
Formulation
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not yet assessed SH-OLIGOPEPTIDE-89 SP. Information specific to its safety profile is limited. However, as certain growth factors (e.g., SH-OLIGOPEPTIDE-1, often equated with EGF) exhibit mitogenic activity, a theoretical caution exists for individuals with pre-existing abnormal cell growth or specific inflammatory conditions like psoriasis. It is important to note that these substances are not classified as mutagenic.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A conclusive evaluation of SH-OLIGOPEPTIDE-89 SP for skincare applications is not possible due to the lack of specific efficacy and safety data.
Related
Similar Ingredients
Finding similar ingredients…